Cargando…

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity

Detalles Bibliográficos
Autor principal:	Averbeck, Marcio Augusto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2022
Materias:	Update in Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747027/ https://www.ncbi.nlm.nih.gov/pubmed/36173410 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.02

Ejemplares similares

Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity
por: Averbeck, Marcio Augusto
Publicado: (2021)

Editorial Comment: Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2021)

Editorial Comment: Sacral neuromodulation for neurogenic Lower Urinary Tract Dysfunction
por: Averbeck, Marcio Augusto
Publicado: (2023)

Editorial Comment: Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: A systematic review
por: Averbeck, Marcio Augusto
Publicado: (2020)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Editorial Comment: Reasons for cessation of clean intermittent catheterization after spinal cord injury: Results from the Neurogenic Bladder Research Group spinal cord injury registry
por: Averbeck, Marcio Augusto
Publicado: (2021)

Editorial Comment: Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years’ Experience and Future Directions
por: Averbeck, Marcio Augusto
Publicado: (2021)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Editorial Comment: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control
por: Averbeck, Marcio Augusto
Publicado: (2020)

Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimuscarinic Treatment
por: Tarcan, Tufan, et al.
Publicado: (2014)

Editorial Comment: Efficiency and satisfaction with telephone consultation of follow-up patients in neuro-urology: Experience of the COVID-19 pandemic
por: Averbeck, Marcio Augusto
Publicado: (2021)

Long-term follow-up after botulinum toxin A (BTX-A) injection into the detrusor for treatment of neurogenic detrusor hyperactivity in children
por: Zeino, Mazen, et al.
Publicado: (2012)

Editorial Comment: An Effective Evidence-Based Cleaning Method for the Safe Reuse of Intermittent Urinary Catheters: In Vitro Testing
por: Averbeck, Marcio Augusto, et al.
Publicado: (2020)

AB204. Repeated intradetrusor botulinum toxin type A injections are still effective for patients with neurogenic detrusor overactivity secondary to spinal cord injury in China
por: Chen, Hui, et al.
Publicado: (2016)

Editorial Comment: The effects of pregabalin, solifenacin and their combination therapy on ureteral double-J stent-related symptoms: A randomized controlled clinical trial
por: Danilovic, Alexandre
Publicado: (2022)

Botulinum toxin in spinal cord injury patients with neurogenic detrusor overactivity
por: Cho, Young Sam, et al.
Publicado: (2016)

Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019)

Antibiotic prophylaxis may not be necessary in patients with asymptomatic bacteriuria undergoing intradetrusor onabotulinumtoxinA injections for neurogenic detrusor overactivity
por: Leitner, Lorenz, et al.
Publicado: (2016)

Editorial Comment: Combination therapy in overactive bladder-untapped research opportunities: A systematic review of the literature
por: Riccetto, Cássio L. Z.
Publicado: (2021)

Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
por: Cohen, Brian L., et al.
Publicado: (2009)

Protocol for a prospective observational study of cortical lower urinary tract control changes following intradetrusor injection of botulinum toxin-A in patients with multiple sclerosis
por: Elizondo, Rodolfo A, et al.
Publicado: (2017)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
por: Wu, Shang-Jun, et al.
Publicado: (2019)

The Botulinum Treatment of Neurogenic Detrusor Overactivity: The Double-Face of the Neurotoxin
por: Traini, Chiara, et al.
Publicado: (2019)

Editorial Comment: Penile prosthesis implant in the special populations: diabetics, neurogenic conditions, fibrotic cases, concurrent urinary continence surgery, and salvage implants
por: Chung, E, et al.
Publicado: (2020)

Editorial Comment: Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study
por: Moreno-Palacios, Jorge
Publicado: (2021)

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)
por: Drake, Marcus J., et al.
Publicado: (2017)

Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport(®)) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
por: Huynh Le Maux, Amélie, et al.
Publicado: (2015)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
por: Wang, Chung-Cheng, et al.
Publicado: (2021)

Editorial Comment: Management of post TURP strictures
por: Kulkarni, SB, et al.
Publicado: (2020)

Editorial Comment: Female urethroplasty: contemporary thinking
por: West, C, et al.
Publicado: (2020)

Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial
por: Barros, Rodrigo de Castro
Publicado: (2022)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
por: Lombardi, Giuseppe, et al.
Publicado: (2017)

Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment
por: Mahajan, Rajiv, et al.
Publicado: (2011)

Editorial Comment: Ascending testis: A congenital predetermined condition
por: Logsdon, Natasha T., et al.
Publicado: (2021)

Editorial Comment: Penile Transplantation: Lessons Learned and Technical Considerations
por: Favorito, Luciano A., et al.
Publicado: (2022)

Editorial Comment: Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial
por: Riccetto, Cássio L. Z.
Publicado: (2021)

Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial
por: Ferreira, Rúiter Silva, et al.
Publicado: (2018)

Editorial comment: Is testosterone replacement an effective treatment of secondary premature ejaculation?
por: Javaroni, Valter
Publicado: (2021)

Editorial Comment: The Basic Physics of Waves, Soundwaves, and Shockwaves for Erectile Dysfunction
por: Javaroni, Valter
Publicado: (2020)

Editorial Comment: Diagnostic performance of MRI and US in suspicion of penile fracture
por: Favorito, Luciano A.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bmhv81e6cko79iaanpnqi0nm5i